PI
VKTX icon

PEAK6 Investments’s Viking Therapeutics VKTX Stock Holding History

PEAK6 Investments’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$4.48M Buy
70,800
+55,800
+372% +$3.27M 0.01% 991
2024
Q2 		$795K Sell
15,000
-10,500
-41% -$688K ﹤0.01% 1983
2024
Q1 		$2.09M Buy
25,500
+20,500
+410% +$912K 0.01% 1398
2023
Q4 		$93K Buy
+5,000
New +$65.4K ﹤0.01% 3578
2023
Q3 		– Sell
-10,700
Closed -$173K – 4626
2023
Q2 		$173K Sell
10,700
-17,700
-62% -$371K ﹤0.01% 2962
2023
Q1 		$473K Buy
+28,400
New +$293K ﹤0.01% 2435
2022
Q3 		– Sell
-10,700
Closed -$173K – 6200
2022
Q2 		$173K Buy
+10,700
New +$26.5K ﹤0.01% 4874

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

PEAK6 Investments's VKTX Position: Q3 2024 in Review

PEAK6 Investments sold out of Viking Therapeutics (VKTX) in Q3 2024, closing a stake of 11,546 shares — an estimated $677K sold.

PEAK6 Investments first reported a position in VKTX in Q2 2022 and held it in 5 quarters. The position peaked at $686K in Q1 2024. 422 funds tracked by Wall St. Rank hold VKTX as of Q3 2024.

  • PEAK6 Investments reported no remaining Viking Therapeutics position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 11,546 Viking Therapeutics shares in Q3 2024, an estimated $677K.
  • PEAK6 Investments first reported a position in Viking Therapeutics in Q2 2022 and held it in 5 quarters.
  • PEAK6 Investments's Viking Therapeutics position peaked at $686K in Q1 2024.
  • 422 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.